This list recognizes many of the key individuals behind the sector’s remarkable growth in New York, including scientists, venture capitalists, government officials, health care executives, real estate developers, philanthropists, and others who have positioned New York as a biotech center.
Dr. Robert Schneider serves as the Albert Sabin Professor of Molecular Pathogenesis at the New York University School of Medicine.
Dr. Sharon Mates is the Founder, Chair, and CEO of Intra-Cellular Therapies [NASDAQ: ITCI].
